Colorectal cancer: current screening guidelines 'may lead to missed diagnoses'
10/25/2013
Up to 10% of colorectal cancers could be missed by current screening programs of people who have a family history of colon polyps. This is according to a study published in the journal Cancer. Colorectal cancer (CRC) is the third leading cause of cancer-related death in the US according to the American Cancer Society. They estimate it will cause around 50,830 deaths this year...
New genetic errors identified that could cause one of the most deadly leukaemias
10/25/2013
Acute dendritic leukaemia is a rare type of leukaemia, but one with the worst prognosis - the average patient survival rate is just 12-14 months - that is difficult to treat...
Treating aggressive lung cancer with the diabetes drug metformin along with radiation and chemotherapy may slow tumor growth and recurrence, suggests new preliminary findings from researchers at the Perelman School of Medicine at the University of Pennsylvania being presented during an oral abstract session October 28 at the 15th World Conference on Lung Cancer...
Bone cancer pain in dogs relieved by neurotoxin
10/25/2013
By the time bone cancer is diagnosed in a pet dog, it is often too late to save the animal's life. Instead, the goal of treatment is to keep the dog as comfortable and free of pain as possible for as long as possible...
'Photoacoustic mammoscope,' could someday be used for routine breast cancer screenings
10/25/2013
Breast cancer is one of the most common forms of cancer and cancer deaths among women worldwide. Routine screening can increase breast cancer survival by detecting the disease early and allowing doctors to address it at this critical stage...
New genetic errors identified that could cause one of the most deadly leukaemias
10/25/2013
Acute dendritic leukaemia is a rare type of leukaemia, but one with the worst prognosis - the average patient survival rate is just 12-14 months - that is difficult to treat...
Treating aggressive lung cancer with the diabetes drug metformin along with radiation and chemotherapy may slow tumor growth and recurrence, suggests new preliminary findings from researchers at the Perelman School of Medicine at the University of Pennsylvania being presented during an oral abstract session October 28 at the 15th World Conference on Lung Cancer...
Bone cancer pain in dogs relieved by neurotoxin
10/25/2013
By the time bone cancer is diagnosed in a pet dog, it is often too late to save the animal's life. Instead, the goal of treatment is to keep the dog as comfortable and free of pain as possible for as long as possible...
'Photoacoustic mammoscope,' could someday be used for routine breast cancer screenings
10/25/2013
Breast cancer is one of the most common forms of cancer and cancer deaths among women worldwide. Routine screening can increase breast cancer survival by detecting the disease early and allowing doctors to address it at this critical stage...
Phase 3 trial of XTANDI™ in chemotherapy-naive patients meets both co-primary endpoints
10/24/2013
Astellas Pharma Inc. and Medivation, Inc. have announced that the Independent Data Monitoring Committee (IDMC) has informed the companies of positive results from a planned interim analysis of the Phase 3 PREVAIL trial of XTANDI (enzalutamide) in more than 1,700 men with metastatic castration-resistant prostate cancer (mCRPC) that has progressed despite androgen deprivation therapy and who have...